BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Jiang J, Wang Z, Liang X, Nie Y, Chang X, Xue H, Li S, Min C. Intranasal MMI-0100 Attenuates Aβ1-42- and LPS-Induced Neuroinflammation and Memory Impairments via the MK2 Signaling Pathway. Front Immunol 2019;10:2707. [PMID: 31849936 DOI: 10.3389/fimmu.2019.02707] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
Number Citing Articles
1 Yan Y, Gao Y, Kumar G, Fang Q, Zhang N, Yan H, Zhang Y, Song L, Li J, Zheng Y, Zhang N, Zhang H, Ma C. Exosomal MicroRNAs modulate the cognitive function in fasudil treated APPswe/PSEN1dE9 transgenic (APP/PS1) mice model of Alzheimer's disease.. [DOI: 10.21203/rs.3.rs-1895492/v1] [Reference Citation Analysis]
2 Morgan D, Berggren KL, Spiess CD, Smith HM, Tejwani A, Weir SJ, Lominska CE, Thomas SM, Gan GN. Mitogen-activated protein kinase-activated protein kinase-2 (MK2) and its role in cell survival, inflammatory signaling, and migration in promoting cancer. Mol Carcinog 2021. [PMID: 34559922 DOI: 10.1002/mc.23348] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
3 D'Mello SR. When Good Kinases Go Rogue: GSK3, p38 MAPK and CDKs as Therapeutic Targets for Alzheimer's and Huntington's Disease. Int J Mol Sci 2021;22:5911. [PMID: 34072862 DOI: 10.3390/ijms22115911] [Cited by in Crossref: 18] [Cited by in F6Publishing: 21] [Article Influence: 18.0] [Reference Citation Analysis]
4 Srivastava S, Rajopadhye R, Dey M, Singh RK. Inhibition of MK2 kinase as a potential therapeutic target to control neuroinflammation in Alzheimer's disease. Expert Opin Ther Targets 2021;25:243-7. [PMID: 33909536 DOI: 10.1080/14728222.2021.1924151] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
5 Jiang J, Chang X, Nie Y, Shen Y, Liang X, Peng Y, Chang M. Peripheral Administration of a Cell-Penetrating MOTS-c Analogue Enhances Memory and Attenuates Aβ1-42- or LPS-Induced Memory Impairment through Inhibiting Neuroinflammation. ACS Chem Neurosci 2021;12:1506-18. [PMID: 33861582 DOI: 10.1021/acschemneuro.0c00782] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
6 Hugon J, Paquet C. The PKR/P38/RIPK1 Signaling Pathway as a Therapeutic Target in Alzheimer's Disease. Int J Mol Sci 2021;22:3136. [PMID: 33808629 DOI: 10.3390/ijms22063136] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 5.0] [Reference Citation Analysis]
7 Shafiq M, Jagavelu K, Iqbal H, Yadav P, Chanda D, Verma NK, Ghosh JK, Gaestel M, Hanif K. Inhibition of Mitogen-Activated Protein Kinase (MAPK)-Activated Protein Kinase 2 (MK2) is Protective in Pulmonary Hypertension. Hypertension 2021;77:1248-59. [PMID: 33641361 DOI: 10.1161/HYPERTENSIONAHA.120.15229] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
8 Bian H, Wang G, Huang J, Liang L, Zheng Y, Wei Y, Wang H, Xiao L, Wang H. Dihydrolipoic acid protects against lipopolysaccharide-induced behavioral deficits and neuroinflammation via regulation of Nrf2/HO-1/NLRP3 signaling in rat. J Neuroinflammation 2020;17:166. [PMID: 32450903 DOI: 10.1186/s12974-020-01836-y] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 10.5] [Reference Citation Analysis]